{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sandpoint",
      "state": "ID",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68222",
      "recalling_firm": "Thorne Research Inc",
      "address_1": "25820 Hwy 2 West",
      "address_2": "N/A",
      "postal_code": "83864",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Visit",
      "distribution_pattern": "Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.",
      "recall_number": "D-1384-2014",
      "product_description": "Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1",
      "product_quantity": "unknown",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.",
      "recall_initiation_date": "20140612",
      "center_classification_date": "20140613",
      "termination_date": "20141015",
      "report_date": "20140625",
      "code_info": "All lot codes",
      "more_code_info": ""
    }
  ]
}